These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19558713)

  • 1. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
    Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
    BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
    Fung HC; Xiromerisiou G; Gibbs JR; Wu YR; Eerola J; Gourbali V; Hellström O; Chen CM; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Hardy J; Singleton AB
    Neurodegener Dis; 2006; 3(6):327-33. PubMed ID: 17192721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
    Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
    Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
    Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
    Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
    Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
    Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
    Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
    Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
    Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
    Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
    Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
    Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
    Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
    Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
    Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
    Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
    Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
    Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
    BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Tau haplotype with Parkinson's disease in the Greek population.
    Fidani L; Kalinderi K; Bostantjopoulou S; Clarimon J; Goulas A; Katsarou Z; Hardy J; Kotsis A
    Mov Disord; 2006 Jul; 21(7):1036-9. PubMed ID: 16552760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.
    Li J; Ruskey JA; Arnulf I; Dauvilliers Y; Hu MTM; Högl B; Leblond CS; Zhou S; Ambalavanan A; Ross JP; Bourassa CV; Spiegelman D; Laurent SB; Stefani A; Charley Monaca C; Cochen De Cock V; Boivin M; Ferini-Strambi L; Plazzi G; Antelmi E; Young P; Heidbreder A; Labbe C; Ferman TJ; Dion PA; Fan D; Desautels A; Gagnon JF; Dupré N; Fon EA; Montplaisir JY; Boeve BF; Postuma RB; Rouleau GA; Ross OA; Gan-Or Z
    Mov Disord; 2018 Jul; 33(6):1016-1020. PubMed ID: 29756641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the MAPT locus with Parkinson's disease.
    Wider C; Vilariño-Güell C; Jasinska-Myga B; Heckman MG; Soto-Ortolaza AI; Cobb SA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2010 Mar; 17(3):483-6. PubMed ID: 19912324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G; Misra AK; Das SK; Ray K; Ray J
    Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
    Zhang J; Song Y; Chen H; Fan D
    Eur Neurol; 2005; 53(1):15-21. PubMed ID: 15627775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
    Winder-Rhodes SE; Hampshire A; Rowe JB; Peelle JE; Robbins TW; Owen AM; Barker RA
    Neurobiol Aging; 2015 Mar; 36(3):1519-28. PubMed ID: 25577413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population.
    Farrer M; Skipper L; Berg M; Bisceglio G; Hanson M; Hardy J; Adam A; Gwinn-Hardy K; Aasly J
    Neurosci Lett; 2002 Apr; 322(2):83-6. PubMed ID: 11958849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.